Video

EDINBURGH – Is population screening for skin cancer worthwhile?

Yes, Dr. Eckhard Breitbart said in a debate at the 15th World Congress on Cancers of the Skin. "Screening is not a diagnostic procedure," he noted. But the potential benefits of screening, including a significant reduction in medical costs, outweigh the potential harms related to false negative or false positive findings, added Dr. Breitbart, a dermatologist in Hamburg, Germany.

In an interview at the meeting, Dr. Breitbart reviewed the findings from his study of the impact of a population-based skin cancer screening program in Germany, and he discussed what research is needed to support such screening elsewhere.

[email protected]

EDINBURGH – Is population screening for skin cancer worthwhile?

Yes, Dr. Eckhard Breitbart said in a debate at the 15th World Congress on Cancers of the Skin. "Screening is not a diagnostic procedure," he noted. But the potential benefits of screening, including a significant reduction in medical costs, outweigh the potential harms related to false negative or false positive findings, added Dr. Breitbart, a dermatologist in Hamburg, Germany.

In an interview at the meeting, Dr. Breitbart reviewed the findings from his study of the impact of a population-based skin cancer screening program in Germany, and he discussed what research is needed to support such screening elsewhere.

[email protected]

EDINBURGH – Is population screening for skin cancer worthwhile?

Yes, Dr. Eckhard Breitbart said in a debate at the 15th World Congress on Cancers of the Skin. "Screening is not a diagnostic procedure," he noted. But the potential benefits of screening, including a significant reduction in medical costs, outweigh the potential harms related to false negative or false positive findings, added Dr. Breitbart, a dermatologist in Hamburg, Germany.

In an interview at the meeting, Dr. Breitbart reviewed the findings from his study of the impact of a population-based skin cancer screening program in Germany, and he discussed what research is needed to support such screening elsewhere.

[email protected]

EDINBURGH – How would you like a smartphone app that offers a personalized sun protection strategy based on location and skin type?

At the 15th World Congress on Cancers of the Skin, Nina Goad, head of communications for the British Association of Dermatologists, discussed an app that does just that: the World UV App. The app, developed by the British Association of Dermatologists, provides daily UV forecasts based on an individual’s location via a smartphone or tablet. In addition, the app fine-tunes UV risk according to skin type.

In a video interview at the meeting, Ms. Goad discussed the app’s development and how patients can use it to improve their approach to sun protection.

[email protected]

EDINBURGH – How would you like a smartphone app that offers a personalized sun protection strategy based on location and skin type?

At the 15th World Congress on Cancers of the Skin, Nina Goad, head of communications for the British Association of Dermatologists, discussed an app that does just that: the World UV App. The app, developed by the British Association of Dermatologists, provides daily UV forecasts based on an individual’s location via a smartphone or tablet. In addition, the app fine-tunes UV risk according to skin type.

In a video interview at the meeting, Ms. Goad discussed the app’s development and how patients can use it to improve their approach to sun protection.

[email protected]

EDINBURGH – How would you like a smartphone app that offers a personalized sun protection strategy based on location and skin type?

At the 15th World Congress on Cancers of the Skin, Nina Goad, head of communications for the British Association of Dermatologists, discussed an app that does just that: the World UV App. The app, developed by the British Association of Dermatologists, provides daily UV forecasts based on an individual’s location via a smartphone or tablet. In addition, the app fine-tunes UV risk according to skin type.

In a video interview at the meeting, Ms. Goad discussed the app’s development and how patients can use it to improve their approach to sun protection.

[email protected]

BARCELONA – Dr. Ann Marie Navar-Boggan has a beef with current American and European cholesterol guidelines, which she believes seriously underestimate the long-term adverse impact of hypercholesterolemia in younger adults.

Here are the data Dr. Navar-Boggan of the Duke Clinical Research Institute, Durham, N.C., presented at the annual congress of the European Society of Cardiology to bolster her argument for more aggressive treatment of hypercholesterolemia in this population.

[email protected]

BARCELONA – Dr. Ann Marie Navar-Boggan has a beef with current American and European cholesterol guidelines, which she believes seriously underestimate the long-term adverse impact of hypercholesterolemia in younger adults.

Here are the data Dr. Navar-Boggan of the Duke Clinical Research Institute, Durham, N.C., presented at the annual congress of the European Society of Cardiology to bolster her argument for more aggressive treatment of hypercholesterolemia in this population.

[email protected]

BARCELONA – Dr. Ann Marie Navar-Boggan has a beef with current American and European cholesterol guidelines, which she believes seriously underestimate the long-term adverse impact of hypercholesterolemia in younger adults.

Here are the data Dr. Navar-Boggan of the Duke Clinical Research Institute, Durham, N.C., presented at the annual congress of the European Society of Cardiology to bolster her argument for more aggressive treatment of hypercholesterolemia in this population.

[email protected]

BARCELONA – An analysis of FRANCE 2 registry showed that local anesthesia during the transfemoral aortic valve replacement procedure is a safe and effective option, compared with general anesthesia.

The study was performed based on data from 2010 and 2011, and at the annual congress of the European Society of Cardiology, Dr. Romain Chopard of the University Hospital of Besançon, Paris, and his coinvestigators reported that the practice is rather common – even routine in some centers – today.

But, performing TAVR under local anesthesia is not common practice in the United States, said Dr. Deepak L. Bhatt, executive director of interventional cardiovascular programs at Brigham and Women’s Hospital and professor of medicine at Harvard Medical School, both in Boston.

In a video, Dr. Bhatt shares his thoughts on performing local anesthesia and why it hasn’t taken hold in the United States. He also shares his advice with physicians who perform the TAVR procedure.

[email protected]

On Twitter @naseemmiller

BARCELONA – An analysis of FRANCE 2 registry showed that local anesthesia during the transfemoral aortic valve replacement procedure is a safe and effective option, compared with general anesthesia.

The study was performed based on data from 2010 and 2011, and at the annual congress of the European Society of Cardiology, Dr. Romain Chopard of the University Hospital of Besançon, Paris, and his coinvestigators reported that the practice is rather common – even routine in some centers – today.

But, performing TAVR under local anesthesia is not common practice in the United States, said Dr. Deepak L. Bhatt, executive director of interventional cardiovascular programs at Brigham and Women’s Hospital and professor of medicine at Harvard Medical School, both in Boston.

In a video, Dr. Bhatt shares his thoughts on performing local anesthesia and why it hasn’t taken hold in the United States. He also shares his advice with physicians who perform the TAVR procedure.

[email protected]

On Twitter @naseemmiller

BARCELONA – An analysis of FRANCE 2 registry showed that local anesthesia during the transfemoral aortic valve replacement procedure is a safe and effective option, compared with general anesthesia.

The study was performed based on data from 2010 and 2011, and at the annual congress of the European Society of Cardiology, Dr. Romain Chopard of the University Hospital of Besançon, Paris, and his coinvestigators reported that the practice is rather common – even routine in some centers – today.

But, performing TAVR under local anesthesia is not common practice in the United States, said Dr. Deepak L. Bhatt, executive director of interventional cardiovascular programs at Brigham and Women’s Hospital and professor of medicine at Harvard Medical School, both in Boston.

In a video, Dr. Bhatt shares his thoughts on performing local anesthesia and why it hasn’t taken hold in the United States. He also shares his advice with physicians who perform the TAVR procedure.

[email protected]

On Twitter @naseemmiller

BARCELONA – Current guidelines recommend more extensive ablation procedures beyond pulmonary vein isolation for persistent atrial fibrillation. At the annual congress of the European Society of Cardiology, Dr. Atul Verma explains in this video interview that the fresh results of STAR-AF 2, the largest-ever randomized trial of popular ablation strategies in persistent AF, turn the conventional wisdom on its head and suggest that less ablation may be more.

[email protected]

BARCELONA – Current guidelines recommend more extensive ablation procedures beyond pulmonary vein isolation for persistent atrial fibrillation. At the annual congress of the European Society of Cardiology, Dr. Atul Verma explains in this video interview that the fresh results of STAR-AF 2, the largest-ever randomized trial of popular ablation strategies in persistent AF, turn the conventional wisdom on its head and suggest that less ablation may be more.

[email protected]

BARCELONA – Current guidelines recommend more extensive ablation procedures beyond pulmonary vein isolation for persistent atrial fibrillation. At the annual congress of the European Society of Cardiology, Dr. Atul Verma explains in this video interview that the fresh results of STAR-AF 2, the largest-ever randomized trial of popular ablation strategies in persistent AF, turn the conventional wisdom on its head and suggest that less ablation may be more.

[email protected]

Janet Cogswell, RN, discusses the updated 2013 Chemotherapy Administration Safety Standards put in place by the American Society of Clinical Oncology (ASCO) and the Oncology Nursing Society.

"The 2013 standards were created to reflect the fact that oral chemotherapy has unique administration problems," Cogswell said during her 2013 AVAHO Meeting presentation.

Janet Cogswell, RN, discusses the updated 2013 Chemotherapy Administration Safety Standards put in place by the American Society of Clinical Oncology (ASCO) and the Oncology Nursing Society.

"The 2013 standards were created to reflect the fact that oral chemotherapy has unique administration problems," Cogswell said during her 2013 AVAHO Meeting presentation.

Janet Cogswell, RN, discusses the updated 2013 Chemotherapy Administration Safety Standards put in place by the American Society of Clinical Oncology (ASCO) and the Oncology Nursing Society.

"The 2013 standards were created to reflect the fact that oral chemotherapy has unique administration problems," Cogswell said during her 2013 AVAHO Meeting presentation.